Medical University of Silesia in Katowice / Śląski Uniwersytet Medyczny w Katowicach (SUM)


University / College

Location:
Katowice, Poland


Research projects with FAU researchers


JANPA: JANPA - Joint Action on Nutrition and Physical Activity (Gesamtprojekt)
Prof. Dr. Alfred Rütten
(01/09/2015 - 30/11/2017)


Publications in cooperation with FAU scientists


Xu, B., Saito, Y., Baumbach, A., Kelbæk, H., van Royen, N., Zheng, M.,... Wijns, W. (2019). 2-Year Clinical Outcomes of an Abluminal Groove–Filled Biodegradable-Polymer Sirolimus-Eluting Stent Compared With a Durable-Polymer Everolimus-Eluting Stent. Jacc-Cardiovascular Interventions, 12(17), 1679-1687. https://dx.doi.org/10.1016/j.jcin.2019.05.001
Wu, W., Jordan, S., Graf, N., Pena, J.D.O., Curram, J., Allanore, Y.,... Puttini, P.S. (2019). Progressive skin fibrosis is associated with a decline in lung function and worse survival in patients with diffuse cutaneous systemic sclerosis in the European Scleroderma Trials and Research (EUSTAR) cohort. Annals of the Rheumatic Diseases, 78(5), 648-656. https://dx.doi.org/10.1136/annrheumdis-2018-213455
Capdevila, J., Bodei, L., Davies, P., Gorbounova, V., Jensen, R.T., Knigge, U.P.,... Wiedenmann, B. (2019). Unmet medical needs in metastatic lung and digestive neuroendocrine neoplasms. Neuroendocrinology, 108(1), 18-25. https://dx.doi.org/10.1159/000493319
Abu-Omar, K., Messing, S., Sarkadi-Nagy, E., Kovács, V., Kaposvari, C., Brukało, K.,... Tecklenburg, E. (2018). Barriers, facilitators and capacities for childhood obesity prevention in 12 European Union Member States: results of a policy-maker survey. Public Health Panorama, 3(4), 360-367.
Merola, E., Zandee, W., De Mestier, L., Klumpen, H.J., Geboes, K.P., Poczkaj, K.,... Munir, A. (2018). Histopathological Revision for Gastroenteropancreatic Neuroendocrine Neoplasms in Expert Centers: Does It Make the Difference? (pp. 144-144).
Jones, D., Boudes, P.F., Swain, M.G., Bowlus, C.L., Galambos, M.R., Bacon, B.R.,... Hirschfield, G.M. (2017). Seladelpar (MBX-8025), a selective PPAR-δ agonist, in patients with primary biliary cholangitis with an inadequate response to ursodeoxycholic acid: a double-blind, randomised, placebo-controlled, phase 2, proof-of-concept study. Lancet Gastroenterology and Hepatology, 2(10), 716-726. https://dx.doi.org/10.1016/S2468-1253(17)30246-7
Gansevoort, R.T., Arici, M., Benzing, T., Birn, H., Capasso, G., Covic, A.,... Van Biesen, W. (2016). Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease: a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best Practice. Nephrology Dialysis Transplantation, 31(3), 337-48. https://dx.doi.org/10.1093/ndt/gfv456
Sandmeier, B., Jaeger, V.K., Nagy, G., Carreira, P.E., Tzankov, A., Widuchowska, M.,... Huegle, T. (2015). Autopsy versus clinical findings in patients with systemic sclerosis in a case series from patients of the EUSTAR database. Clinical and Experimental Rheumatology, 33 Suppl 9(4), 75-9.
Mann, J., Rossing, P., Wiecek, A., Rosivall, L., Mark, P., & Mayer, G. (2015). Diagnosis and treatment of early renal disease in patients with type 2 diabetes mellitus: what are the clinical needs? Nephrology Dialysis Transplantation, 30 Suppl 4, iv1-5. https://dx.doi.org/10.1093/ndt/gfv120

Last updated on 2017-08-04 at 11:50